borneol
Botanicalexperimental
Borneol is a bicyclic organic compound and a terpene derivative. The hydroxyl group in this compound is placed in an endo position. The exo diastereomer is called isoborneol. Being chiral, borneol exists as enantiomers, both of which are found in nature: d-borneol and l-borneol. — Wikipedia
Clinical trial activity
9 trials · 64 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
4
Phase 4
0
Earliest trial started Oct 1, 2012 (NCT02029118)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CC1(C)C2CCC1(C)C(O)C2- Mol. weight
- 154.25 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaBorneol ↗
- ChEMBLCHEMBL1097205 ↗
Also known as
- borneol
- borneol
- borneol
- isoborneol
- isoborneol, (1r-endo)-isomer
- isoborneol, (1r-exo)-isomer
- isoborneol, (1s-endo)-isomer
- isoborneol, (1s-exo)-isomer
- isoborneol, (endo-(+-))-isomer
- isoborneol, (endo)-isomer
- isoborneol, (exo)-isomer
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05940883 | Phase 1 | Sep 6, 2023 | Parexel, Simcere Pharmaceutical Co., Ltd |
| NCT05159947 | Phase 3 | Dec 31, 2021 | Beijing Haijinge medicine Science-tech CO., Central South University, Changjiang Shipping General Hospital, Daqing Oil Field Hospital, Daqing people's Hospital, Deyang People's Hospital, Dezhou People's Hospital,Shandong, Enshi Tujia and Miao Autonomous Prefecture Central Hospital, Fukuang General Hospital of Liaoning health industry group, Government of China, Guangzhou Red Cross Hospital, Hainan People's Hospital, Harbin Medical University, Hebei University, Hengshui People's Hospital, Huanggang Central Hospital, Huazhong University of Science and Technology, Inner Mongolia Baogang Hospital, Inner Mongolia Medical University, Inner Mongolia University of Science and Technology, Jiangsu Taizhou People's Hospital, Jiaxing Maternity and Child Health Care Hospital, Jingzhou Central Hospital, jining medical college, Jinlin University, Linfen Central Hospital, Meihekou Central Hospital, Nanhua University, Nanyang Medical College, Nanyang nanshai hospital, Neijiang Second People's Hospital, People's Hospital Of Yichang, Qingdao Central Hospital, Qingdao University, Qiqihar Medical College, Qujing first people's Hospital, Shanghai Xuhui District Central Hospital, Shihezi University Medical College, Sinopharm Dongfeng General Hospital, Suzhou Huyun New Drug Research and Development Co., Ltd, Tai'an Central Hospital, Taizhou Hospital of Zhejiang Province, Tancheng first people's Hospital, Tianjin Medical University, Weihai Municipal Hospital, Wuhan Central Hospital, Wuhan NO. 4 hospital, Wuhan University, Xiamen University, Xi’an Gaoxin Hospital, Xiangtan Central Hospital, Xiang Yang NO.1 People's Hospital, Xuancheng people's hospital, Xuzhou Medical University, Yan'an University Affiliated Hospital, Zhangzhou Municipal Hospital of Fujian Province |
| NCT04993729 | Phase 3 | Jul 21, 2021 | Tasly Pharmaceuticals, Inc., University of California, San Francisco |
| NCT04950920 | Phase 3 | Dec 1, 2020 | Peking University |
| NCT03789552 | Phase 3 | Jul 28, 2019 | Tasly Pharmaceuticals, Inc. |
| NCT03552263 | Phase 2 | Jun 7, 2018 | Tasly Pharmaceuticals, Inc., University of California, San Francisco |
| NCT03495206 | Phase 1 | Apr 30, 2018 | Yantai YenePharma Co., Ltd. |
| NCT02029118 | Early Phase 1 (Phase 1) | Oct 1, 2012 | Chengdu University of Traditional Chinese Medicines |
| NCT04646031 | N/A | — | MultiCare Health System Research Institute, Tasly Pharmaceuticals, Inc. |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (64)
64 organizations
Page 1 / 4